This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Gjalt Huisman, PhD
Advisor to Baruch Future Ventures at Founder & CEO, Embold Therapeutics
Speaker

Profile

Gjalt Huisman is an Advisor to Baruch Future Ventures a pioneering, climate-tech focused, family investment firm. He is currently Founder & CEO of Embold Therapeutics, Inc., a biotechnology company focused on developing therapeutics for degenerative diseases of aging. His career spans the world of synthetic biology with a track record of discovering biologics as well as developing enzymatic manufacturing processes for specialty and commodity chemicals. Most recently he built Codexis’ Biotherapeutics business, leading to a clinical pipeline of therapeutic enzymes for rare genetic diseases related to amino acid and lysosomal metabolism.

Agenda Sessions

  • Cracking the Code – Investor Insights into Rare Disease Funding Opportunities

    1:30pm